0 Comments
0 Shares
1K Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
API Outsourcing Drives Small Molecule CDMO Market Toward USD 133.63 Billion Valuation by 2034Small Molecule CDMO Market to Reach USD 133.63 Billion by 2034, Growing at 6.5% CAGR: Polaris Market Research According to a new report by Polaris Market Research, the global Small Molecule CDMO market was valued at USD 71.25 billion in 2024 and is projected to reach USD 133.63 billion by 2034, expanding at a CAGR of 6.5% over the forecast period. The market stood at an estimated USD 75.81...0 Comments 0 Shares 103 Views 0 Reviews
-
Small Molecule API CDMO Market Analysis of Regional Growth PatternsThe global small molecule API CDMO market size was valued at USD 46.59 billion in 2025 and is projected to reach USD 80.74 billion by 2033, growing at a CAGR of 7.28% from 2026 to 2033. The market is experiencing growth driven by rising demand for complex APIs and advanced manufacturing capabilities, increasing geopolitical shifts and supply chain resilience initiatives,...0 Comments 0 Shares 433 Views 0 Reviews
-
Active Pharmaceutical Ingredients Market Gains Momentum From Complex Drug DevelopmentThe Active Pharmaceutical Ingredients Market is expanding alongside the global need for medicines, with pharmaceutical manufacturers responding to rising chronic disease prevalence, an aging population, and increasing demand for generic and innovative therapies. The market reached USD 270.5 billion in 2025 and is projected to reach USD 419.0 billion by 2033, registering...0 Comments 0 Shares 434 Views 0 Reviews
-
Pharmaceutical Contract Manufacturing Market Forecast and Competitive LandscapeThe global Pharmaceutical Contract Manufacturing Market size was valued at USD 141.7 billion in 2025 and is projected to grow from USD 155.1 billion in 2026 to USD 310.9 billion by 2033, registering a CAGR of 10.4% from 2026 to 2033. North America accounted for the largest market share of 38.44% in 2025, supported by a mature pharmaceutical ecosystem, robust R&D investments, and...0 Comments 0 Shares 867 Views 0 Reviews